ZA889269B - Fatty acid compositions - Google Patents

Fatty acid compositions

Info

Publication number
ZA889269B
ZA889269B ZA889269A ZA889269A ZA889269B ZA 889269 B ZA889269 B ZA 889269B ZA 889269 A ZA889269 A ZA 889269A ZA 889269 A ZA889269 A ZA 889269A ZA 889269 B ZA889269 B ZA 889269B
Authority
ZA
South Africa
Prior art keywords
fatty acid
acid compositions
dgla
gla
cyclosporin
Prior art date
Application number
ZA889269A
Other languages
English (en)
Inventor
David Frederick Horrobin
Frederick Horrobin David
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA889269B publication Critical patent/ZA889269B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA889269A 1987-12-14 1988-12-12 Fatty acid compositions ZA889269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729153A GB8729153D0 (en) 1987-12-14 1987-12-14 Fatty acid compositions

Publications (1)

Publication Number Publication Date
ZA889269B true ZA889269B (en) 1989-08-30

Family

ID=10628481

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889269A ZA889269B (en) 1987-12-14 1988-12-12 Fatty acid compositions

Country Status (15)

Country Link
US (1) US4970076A (xx)
EP (1) EP0321128B1 (xx)
JP (1) JP2722227B2 (xx)
KR (1) KR970010542B1 (xx)
AT (1) ATE72988T1 (xx)
AU (1) AU616713B2 (xx)
CA (1) CA1335789C (xx)
DE (1) DE3868886D1 (xx)
ES (1) ES2033442T3 (xx)
GB (1) GB8729153D0 (xx)
GR (1) GR3003991T3 (xx)
HK (1) HK129593A (xx)
IE (1) IE61698B1 (xx)
NZ (1) NZ227241A (xx)
ZA (1) ZA889269B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4750057A (en) * 1985-12-30 1988-06-07 Eastman Kodak Company De-interlacing circuit for simultaneous readout of paired fields
CH679119A5 (xx) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
US5264217A (en) * 1990-01-30 1993-11-23 Efamol Holdings Ltd. Method of increasing the total fat content of milk
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
SK278290B6 (en) * 1992-09-07 1996-08-07 Milan Stuchlik Medicaments with n-methylated cyclic undecapeptides
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
CA2220091C (en) * 1995-05-01 2011-01-04 Scotia Holdings Plc Nicotinic acid esters and pharmaceutical compositions containing them
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
US6696413B2 (en) 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DE69842121D1 (de) * 1997-12-10 2011-03-17 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
PL348193A1 (en) 1998-12-11 2002-05-06 Pharmasolutions Self-emulsifying compositions for drugs poorly soluble in water
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
NZ531944A (en) 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
WO2004071510A1 (en) * 2003-02-11 2004-08-26 Cipla Ltd Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
DE102005061409A1 (de) 2005-12-22 2007-06-28 Robert Bosch Gmbh Elektromagnetisch betätigbares Ventil
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2480208A1 (en) 2009-09-23 2012-08-01 Indu Javeri Methods for the preparation of liposomes
CA2852056C (en) 2011-03-11 2021-08-10 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
KR102391827B1 (ko) 2014-06-04 2022-04-27 디에스 바이오파마 리미티드 Dgla를 포함하는 약제학적 조성물 및 그의 용도
AU2016315873B2 (en) 2015-09-04 2022-08-18 Primatope Therapeutics Inc. Humanized anti-CD40 antibodies and uses thereof
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196189A (en) * 1977-03-19 1980-04-01 Blendax-Werke R. Schneider Dental and oral hygiene preparations
ATE43335T1 (de) * 1980-02-14 1989-06-15 Sandoz Ag Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
AU1089683A (en) * 1982-02-08 1983-08-18 Smithkline Beckman Corporation Antifungal composition
DE3366506D1 (en) * 1982-03-01 1986-11-06 Efamol Ltd Pharmaceutical composition
HU197733B (en) * 1985-05-29 1989-05-29 Chinoin Gyogyszer Es Vegyeszet Process for producing ephedrin-salts of 7-oxo-prosta-cyclin derivatives
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
WO1987006463A1 (en) * 1986-05-02 1987-11-05 Brigham And Women's Hospital A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine

Also Published As

Publication number Publication date
GB8729153D0 (en) 1988-01-27
IE883626L (en) 1989-06-14
NZ227241A (en) 1991-05-28
KR970010542B1 (ko) 1997-06-28
EP0321128A1 (en) 1989-06-21
DE3868886D1 (de) 1992-04-09
AU616713B2 (en) 1991-11-07
US4970076A (en) 1990-11-13
KR890009383A (ko) 1989-08-01
GR3003991T3 (xx) 1993-03-16
CA1335789C (en) 1995-06-06
HK129593A (en) 1993-12-03
EP0321128B1 (en) 1992-03-04
JPH0276819A (ja) 1990-03-16
JP2722227B2 (ja) 1998-03-04
AU2677888A (en) 1989-06-15
IE61698B1 (en) 1994-11-16
ATE72988T1 (de) 1992-03-15
ES2033442T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
IE883626L (en) Fatty acid compositions
EP0334507A3 (en) Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
ES2060290T3 (es) Composiciones de acidos grasos esenciales (efa) y terapia.
AU1821888A (en) Treatment or prevention of memory loss using essential fatty acid compositions
EP0295954A3 (en) Compositions for the treatment of periodontal disease
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
AU1539188A (en) TGF-B2 and novel compositions having anti-neoplastic activity
IL98156A0 (en) Pharmaceutical compositions containing magnesium-pyridoxal-5'-phosphate-glutaminate
IL81800A0 (en) 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same
AU7018187A (en) Iron - containing composition and method for treatment of cancer
EG20191A (en) Novel 3,3'- dithobis (propionic acids) and esters thereof
EP0313517A3 (en) Aliphatic esters of 1,3,2-oxazaphospholidines
NZ224363A (en) Ophthalmological compositions
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
ES2009569A6 (es) Procedimiento de preparacion de una composicion farmaceutica a base de algas que contengan selenio que actua sobre el corazon y el sistema cardiovascular.
IE882836L (en) Antiviral preparations
EP0303435A3 (en) Bipolar transistors
GB2206903B (en) Concentrated compositions and their use as stabilizers for peroxide-containing alkaline liquors
AU2343988A (en) Captopril and diltiazem compositions and uses thereof
EP0468327A3 (en) Oral pharmaceutical compositions containing hirudin
IE881991L (en) Homocyclostatine and cyclostatine containing polypeptides as¹antihypertensive agents
GB8710618D0 (en) Bipolar transistors
EP0301352A3 (en) Olefinic diphosphonic acids, process for their preparation and their use as threshold agents, as well as complexant compositions containing olefinic diphosphonic acids
GB8711300D0 (en) Bipolar transistors